表紙
市場調查報告書
商品編碼
819826

灌注系統的全球市場分析及預測(各類型,各零件,各地區)

Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type ; Component and Geography

出版日期: | 出版商: The Insight Partners | 英文 167 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球灌系統市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業的簡介等相關資訊。

第1章 簡介

第2章 市場概要

第3章 調查方法

第4章 市場情況

  • 概要
  • PEST分析

第5章 市場趨勢

  • 促進要素
  • 阻礙要素
  • 市場機會
  • 影響分析

第6章 世界分析

  • 收益預測與分析
  • 各地區預測與分析
  • 主要加入企業的實際成果
  • 專家的見解

第7章 各類型市場

  • 概要
  • 各類型市場
  • 微流體灌注系統
  • 小型哺乳類器官灌注系統
  • 生物反應器灌注系統
  • 重力或壓力驅動灌注系統

第8章 各零件市場

  • 概要
  • 各零件市場
  • 灌注幫浦
  • 氧供給器
  • 心肺設備
  • 監控系統
  • 導管
  • 其他

第9章 各地區市場

  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第10章 產業趨勢

  • 概要
  • 成長策略
  • 有機的發展
  • 內部成長策略
  • 產品核可
  • 產品上市
  • 無機的發展
  • 無機的成長策略
  • 收購
  • 聯盟
  • 聯合
  • 協定

第11章 企業簡介

第12章 附錄

目錄
Product Code: TIPMD00002293

The global perfusion systems market is expected to reach US$ 1,442.28 Mn in 2027 from US$ 1,044.75 Mn in 2018. The market is estimated to grow with a CAGR of 3.8% from 2019-2027.

The growth of the perfusion systems market is primarily attributed to the rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation, and rising cell based research activities. However, expensive organ transplant surgeries, and limited numbers of donors for organ transplant surgeries are likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions is likely to have a positive impact on the growth of the global perfusion systems market in the coming years. Cardiovascular diseases (CVDs) is the leading cause of death across the globe, it affects more people as compared to any other disease. Other than the lifestyle and habit older people are more prone to the cardiovascular diseases. The ageing population commonly show the structural and functional alteration of vessels accumulation through their life. Thus it increases the risk of developing cardiovascular diseases. The prevalence of the cardiovascular diseases is increasing across the world. The key factors that lead to the occurrence of cardiovascular diseases among the population. As per the American College of Cardiology, it is stated that CVD contributes nearly 800,000deaths in the US, which is approximately to one out every three deaths. The coronary heart disease (CHD) contributes to the majority of CVD deaths which is further followed by stroke and heart failure. Nearly over 90 million Americans get diagnosed with CVD. In addition, it is stated that at a global level cardiovascular diseases contributes around 31% of all deaths and is expected that the cost of the CVD will be approximately to US$ 1,044 billion by 2030.

In 2018, the perfusion systems with bioreactor segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to the increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, scalability. Moreover, the microfluidic perfusion systems segment is anticipated to also witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to provide application at point of care.

Global perfusion systems market, based on component was segmented into oxygenators, heart-lung machines, perfusion pumps, monitoring systems, cannulas, and others. The oxygenators segment is anticipated to grow at a CAGR of 4.4% during the forecast period. The increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation across the world is likely to contribute to the growth and dominance of the segment. The oxygenators segment is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.

Some of the major primary and secondary sources for perfusion systems included in the report are Australasian Board of Cardiovascular Perfusion, Board of Cardiovascular Perfusion India, China Food & Drug Administration, contract research organizations, Food and Drug Administration, New Mexico Asthma Control Program and among others.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the perfusion systems market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global perfusion systems treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1 SCOPE OF THE STUDY
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3 MARKET SEGMENTATION
    • 1.3.1 Global Perfusion Systems Market - By Type
    • 1.3.2 Global Perfusion Systems Market - By Component
    • 1.3.3 Global Perfusion Systems Market - By Geography

2. GLOBAL PERFUSION SYSTEMS MARKET - KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

    • 3.1.1 Coverage
    • 3.1.2 Secondary Research
    • 3.1.3 Primary Research

4. GLOBAL PERFUSION SYSTEMS MARKET - MARKET LANDSCAPE

  • 4.1 OVERVIEW
  • 4.2 PEST ANALYSIS
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & South Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis

5. GLOBAL PERFUSION SYSTEMS MARKET - KEY MARKET DYNAMICS

  • 5.1 KEY MARKET DRIVERS
    • 5.1.1 Rising Prevalence of Cardiovascular Diseases
    • 5.1.2 Significant Growth of Pharmaceutical and Biotechnology Industries
    • 5.1.3 Rising Need for The Organ Transplantation
    • 5.1.4 Rising Cell Based Research Activities
  • 5.2 KEY MARKET CHALLENGES
    • 5.2.1 Expensive Organ Transplant Surgeries
    • 5.2.2 Limited Numbers of Donors for Organ Transplant Surgeries
  • 5.3 KEY MARKET OPPORTUNITIES
    • 5.3.1 Growth Opportunities in Emerging Regions
  • 5.4 IMPACT ANALYSIS

6. PERFUSION SYSTEMS MARKET - GLOBAL ANALYSIS

  • 6.1 GLOBAL PERFUSION SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS
  • 6.2 GLOBAL PERFUSION SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
  • 6.3 PERFORMANCE OF KEY PLAYERS
    • 6.3.1 Getinge AB
    • 6.3.2 Medtronic
  • 6.4 EXPERT OPINIONS

7. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY TYPE

  • 7.1 OVERVIEW
  • 7.2 GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, 2018 & 2027 (%)
  • 7.3 MICROFLUIDIC PERFUSION SYSTEMS MARKET
    • 7.3.1 Overview
    • 7.3.2 Global Microfluidic Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET
    • 7.4.1 Overview
    • 7.4.2 Global Small-Mammal Organ Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.5 BIOREACTORS PERFUSION SYSTEMS MARKET
    • 7.5.1 Overview
    • 7.5.2 Global Bioreactors Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.6 GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET
    • 7.6.1 Overview
    • 7.6.2 Global Gravity or Pressure-Driven Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)

8. GLOBAL PERFUSION SYSTEMS MARKET ANALYSIS- BY COMPONENT

  • 8.1 OVERVIEW
  • 8.2 GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
  • 8.3 PERFUSION PUMPS MARKET
    • 8.3.1 Overview
    • 8.3.2 Global Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 OXYGENATORS MARKET
    • 8.4.1 Overview
    • 8.4.2 Global Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.5 HEART LUNG MACHINE MARKET
    • 8.5.1 Overview
    • 8.5.2 Global Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.6 MONITORING SYSTEMS MARKET
    • 8.6.1 Overview
    • 8.6.2 Global Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.7 CANNULAS MARKET
    • 8.7.1 Overview
    • 8.7.2 Global Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.8 OTHERS MARKET
    • 8.8.1 Overview
    • 8.8.2 Global Others Market Revenue and Forecasts to 2027 (US$ Mn)

9. PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

  • 9.1 NORTH AMERICA PERFUSION SYSTEMS MARKET
    • 9.1.1 Overview
    • 9.1.2 North America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.3 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.1.4 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.1.5 North America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.6 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.7 US Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 US Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.2 US Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.1.8 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.9 Canada Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.9.1 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.9.2 Canada Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.1.10 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.11 Mexico Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.11.1 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.1.11.2 Mexico Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
  • 9.2 EUROPE PERFUSION SYSTEMS MARKET
    • 9.2.1 Overview
    • 9.2.2 Europe Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.3 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.2.4 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.2.5 Europe Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
    • 9.2.6 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.7 Germany Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.1 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.7.2 Germany Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.2.8 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.9 UK Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.1 UK Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.9.2 UK Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.2.10 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.11 France Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.11.1 France Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.11.2 France Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.2.12 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.13 Spain Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.13.1 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.13.2 Spain Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.2.14 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.15 Italy Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.15.1 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.2.15.2 Italy Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
  • 9.3 ASIA PACIFIC PERFUSION SYSTEMS MARKET
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.3 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.3.4 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.3.5 Asia Pacific Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
    • 9.3.6 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.7 China Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.1 China Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.7.2 China Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.3.8 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.9 Japan Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.9.1 Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.9.2 Japan Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.3.10 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.11 India Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.11.1 India Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.11.2 India Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.3.12 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.13 Australia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.13.1 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.13.2 Australia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.3.14 South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.15 South Korea Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.15.1 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.3.15.2 South Korea Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
  • 9.4 MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET
    • 9.4.1 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.2 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.4.3 Middle East & Africa Perfusion Systems Market Revenue And Forecasts to 2027, By Component (US$ Mn)
    • 9.4.4 Middle East & Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
    • 9.4.5 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.6 UAE Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.6.1 UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.6.2 UAE Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.4.7 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.8 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.8.1 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.8.2 Saudi Arabia Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.4.9 South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.10 South Africa Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.4.10.1 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.4.10.2 South Africa Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
  • 9.5 SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET
    • 9.5.1 Overview
    • 9.5.2 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5.3 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
    • 9.5.4 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.5.5 South and Central America Perfusion Systems Market Revenue and Forecasts to 2027, By Country (%)
    • 9.5.6 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5.7 Brazil Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.7.1 Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.7.2 Brazil Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)
    • 9.5.8 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.5.9 Argentina Perfusion Systems Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.9.1 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Type (US$ Mn)
      • 9.5.9.2 Argentina Perfusion Systems Market Revenue and Forecasts to 2027, By Component (US$ Mn)

10. PERFUSION SYSTEMS MARKET -INDUSTRY LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • 10.3 ORGANIC DEVELOPMENTS
    • 10.3.1 Overview
  • 10.4 ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2016-2018
  • 10.5 PRODUCT APPROVAL
    • 10.5.1 Recent Product Approval by Players in the Perfusion Systems Market, 2015-2018
  • 10.6 PRODUCT LAUNCH
    • 10.6.1 Recent Product Launch by Players in the Perfusion Systems Market, 2015-2018
  • 10.7 OTHERS
    • 10.7.1 Others Organic Strategies Made by the Players in the Perfusion Systems Market, 2015-2018
  • 10.8 INORGANIC DEVELOPMENTS
    • 10.8.1 Overview
  • 10.9 INORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • 10.10 ACQUISITION
    • 10.10.1 Acquisition Made by the Players in the perfusion systems Market, 2015-2018
  • 10.11 PARTNERSHIPS
    • 10.11.1 Recent Partnership by Players in the Perfusion Systems Market, 2015-2018
  • 10.12 COLLABORATION
    • 10.12.1 Collaboration by Players in the Perfusion Systems Market, 2015-2018
  • 10.13 AGREEMENT
    • 10.13.1 Agreement Made by the Players in the Perfusion Systems Market, 2015-2018

11. PERFUSION SYSTEMS MARKET-KEY COMPANY PROFILES

  • 11.1 EXISTING PLAYERS
    • 11.1.1 REPLIGEN CORPORATION
      • 11.1.1.1 Key Facts
      • 11.1.1.2 Business Description
      • 11.1.1.3 Financial Overview
      • 11.1.1.4 Product Portfolio
      • 11.1.1.5 SWOT Analysis
      • 11.1.1.6 Key Developments
    • 11.1.2 Merck KGaA
      • 11.1.2.1 Key Facts
      • 11.1.2.2 Business Description
      • 11.1.2.3 Financial Overview
      • 11.1.2.4 Product Portfolio
      • 11.1.2.5 SWOT Analysis
      • 11.1.2.6 Key Developments
    • 11.1.3 ALA Scientific Instruments, Inc.
      • 11.1.3.1 Key Facts
      • 11.1.3.2 Business Description
      • 11.1.3.3 Financial Overview
      • 11.1.3.4 Product Portfolio
      • 11.1.3.5 SWOT Analysis
      • 11.1.3.6 Key Developments
    • 11.1.4 XVIVO Perfusion
      • 11.1.4.1 Key Facts
      • 11.1.4.2 Business Description
      • 11.1.4.3 Financial Information
      • 11.1.4.4 Product Portfolio
      • 11.1.4.5 SWOT Analysis
      • 11.1.4.6 Key Developments
    • 11.1.5 Medtronic
      • 11.1.5.1 Key Facts
      • 11.1.5.2 Business Description
      • 11.1.5.3 Financial Information
      • 11.1.5.4 Product Portfolio
      • 11.1.5.5 SWOT Analysis
      • 11.1.5.6 Key Developments
    • 11.1.6 XENIOS AG (Fresenius Medical Care AG & Co. KGaA)
      • 11.1.6.1 Key Facts
      • 11.1.6.2 Business Description
      • 11.1.6.3 Financial Information
      • 11.1.6.4 Product Portfolio
      • 11.1.6.5 SWOT Analysis
      • 11.1.6.6 Key Developments
    • 11.1.7 TERUMO CORPORATION
      • 11.1.7.1 Key Facts
      • 11.1.7.2 Business Description
      • 11.1.7.3 Financial Overview
      • 11.1.7.4 Product Portfolio
      • 11.1.7.5 SWOT Analysis
      • 11.1.7.6 Key Developments
    • 11.1.8 Getinge AB
      • 11.1.8.1 Key Facts
      • 11.1.8.2 Business Description
      • 11.1.8.3 Financial Overview
      • 11.1.8.4 Product Portfolio
      • 11.1.8.5 SWOT Analysis
      • 11.1.8.6 Key Developments
    • 11.1.9 Harvard Bioscience
      • 11.1.9.1 Key Facts
      • 11.1.9.2 Business Description
      • 11.1.9.3 Financial Overview
      • 11.1.9.4 Product Portfolio
      • 11.1.9.5 SWOT Analysis
      • 11.1.9.6 Key Developments
    • 11.1.10 OrganOx
      • 11.1.10.1 Key Facts
      • 11.1.10.2 Business Description
      • 11.1.10.3 Financial Overview
      • 11.1.10.4 Product Portfolio
      • 11.1.10.5 SWOT Analysis
      • 11.1.10.6 Key Developments
  • 11.2 EMERGING PLAYERS
    • 11.2.1 Sartorius AG
      • 11.2.1.1 Key Facts
      • 11.2.1.2 Business Description
      • 11.2.1.3 Financial Overview
      • 11.2.1.4 Product Portfolio
      • 11.2.1.5 SWOT Analysis
      • 11.2.1.6 Key Developments
    • 11.2.2 RAND
      • 11.2.2.1 Key Facts
      • 11.2.2.2 Business Description
      • 11.2.2.3 Financial Overview
      • 11.2.2.4 Product Portfolio
      • 11.2.2.5 SWOT Analysis
      • 11.2.2.6 Key Developments
    • 11.2.3 LivaNova PLC
      • 11.2.3.1 Key Facts
      • 11.2.3.2 Business Description
      • 11.2.3.3 Financial Overview
      • 11.2.3.4 Product Portfolio
      • 11.2.3.5 SWOT Analysis
      • 11.2.3.6 Key Developments
    • 11.2.4 Sanisure (Sani-Tech West, Inc.)
      • 11.2.4.1 Key Facts
      • 11.2.4.2 Business Description
      • 11.2.4.3 Financial Overview
      • 11.2.4.4 Product Portfolio
      • 11.2.4.5 SWOT Analysis
      • 11.2.4.6 Key Developments
    • 11.2.5 AutoMate Scientific, Inc.
      • 11.2.5.1 Key Facts
      • 11.2.5.2 Business Description
      • 11.2.5.3 Financial Overview
      • 11.2.5.4 Product Portfolio
      • 11.2.5.5 SWOT Analysis
      • 11.2.5.6 Key Developments
    • 11.2.6 APD (Advanced Perfusion Diagnostics)
      • 11.2.6.1 Key Facts
      • 11.2.6.2 Business Description
      • 11.2.6.3 Financial Overview
      • 11.2.6.4 Product Portfolio
      • 11.2.6.5 SWOT Analysis
      • 11.2.6.6 Key Developments
    • 11.2.7 Spectrum Medical
      • 11.2.7.1 Key Facts
      • 11.2.7.2 Business Description
      • 11.2.7.3 Financial Overview
      • 11.2.7.4 Product Portfolio
      • 11.2.7.5 SWOT Analysis
      • 11.2.7.6 Key Developments
    • 11.2.8 Transonic Systems Inc.
      • 11.2.8.1 Key Facts
      • 11.2.8.2 Business Description
      • 11.2.8.3 Financial Overview
      • 11.2.8.4 Product Portfolio
      • 11.2.8.5 SWOT Analysis
      • 11.2.8.6 Key Developments
    • 11.2.9 ISCHEMAVIEW, INC
      • 11.2.9.1 Key Facts
      • 11.2.9.2 Business Description
      • 11.2.9.3 Financial Overview
      • 11.2.9.4 Product Portfolio
      • 11.2.9.5 SWOT Analysis
      • 11.2.9.6 Key Developments
    • 11.2.10 CESCO BIOENGINEERING CO., LTD.
      • 11.2.10.1 Key Facts
      • 11.2.10.2 Business Description
      • 11.2.10.3 Financial Overview
      • 11.2.10.4 Product Portfolio
      • 11.2.10.5 SWOT Analysis
      • 11.2.10.6 Key Developments
    • 11.2.11 Jobst Technologies GmbH
      • 11.2.11.1 Key Facts
      • 11.2.11.2 Business Description
      • 11.2.11.3 Financial Overview
      • 11.2.11.4 Product Portfolio
      • 11.2.11.5 SWOT Analysis
      • 11.2.11.6 Key Developments

12. APPENDIX

  • 12.1 ABOUT THE INSIGHT PARTNERS
  • 12.2 GLOSSARY OF TERMS

LIST OF TABLES

  • TABLE 1. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 2. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 3. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 4. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 5. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 6. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 7. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 8. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 9. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 10. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 11. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 12. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 13. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 14. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 15. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 16. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 17. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 18. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 19. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 20. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 21. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 22. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 23. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 24. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 25. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 26. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 27. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 28. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 29. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 30. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 31. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 32. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 33. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 34. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 35. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 36. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 37. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 38. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 39. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 40. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 41. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 42. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 43. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 44. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 45. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY TYPE (US$ MN)
  • TABLE 46. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COMPONENT (US$ MN)
  • TABLE 47. RECENT PRODUCT APPROVAL BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 48. RECENT PRODUCT LAUNCH BY PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 49. OTHERS ORGANIC STRATEGIES MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 50. ACQUISITION MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 51. RECENT PARTNERSHIP IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 52. COLLABORATION IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 53. AGREEMENT MADE BY THE PLAYERS IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • TABLE 54. GLOSSARY OF TERMS, PERFUSION SYSTEMS MARKET

LIST OF FIGURES

  • FIGURE 1. PERFUSION SYSTEMS MARKET SEGMENTATION
  • FIGURE 2. PERFUSION SYSTEMS SEGMENTATION, BY REGION
  • FIGURE 3. ASIA PACIFIC PERFUSION SYSTEMS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2027
  • FIGURE 4. GLOBAL PERFUSION SYSTEMS MARKET BY TYPE, MARKET SHARE (%), 2018
  • FIGURE 5. GLOBAL PERFUSION SYSTEMS MARKET BY COMPONENT, MARKET SHARE (%), 2018
  • FIGURE 6. NORTH AMERICA PEST ANALYSIS
  • FIGURE 7. EUROPE PEST ANALYSIS
  • FIGURE 8. ASIA PACIFIC PEST ANALYSIS
  • FIGURE 9. MIDDLE EAST & SOUTH AFRICA PEST ANALYSIS
  • FIGURE 10. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
  • FIGURE 11. PERFUSION SYSTEMS MARKET IMPACT ANALYSIS OF DRIVER AND CHALLENGES
  • FIGURE 12. GLOBAL PERFUSION SYSTEMS MARKET - REVENUE FORECASTS AND ANALYSIS -2018- 2027
  • FIGURE 13. GLOBAL PERFUSION SYSTEMS MARKET - BY GEOGRAPHY FORECASTS AND ANALYSIS - 2018- 2027
  • FIGURE 14. GLOBAL PERFUSION SYSTEMS MARKET, BY TYPE 2018 & 2027 (%)
  • FIGURE 15. GLOBAL MICROFLUIDIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 16. GLOBAL SMALL-MAMMAL ORGAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 17. GLOBAL BIOREACTORS PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 18. GLOBAL GRAVITY OR PRESSURE-DRIVEN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 19. GLOBAL PERFUSION SYSTEMS MARKET, BY COMPONENT 2018 & 2027 (%)
  • FIGURE 20. GLOBAL PERFUSION PUMPS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 21. GLOBAL OXYGENATORS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 22. GLOBAL HEART-LUNG MACHINE MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 23. GLOBAL MONITORING SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 24. GLOBAL CANNULAS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 25. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 26. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 27. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 28. NORTH AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 29. US PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 30. CANADA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 31. MEXICO PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 32. EUROPE PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 33. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 34. EUROPE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 35. GERMANY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 36. UK PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 37. FRANCE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 38. SPAIN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 39. ITALY PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 40. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 41. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 42. ASIA PACIFIC PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 43. CHINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 44. JAPAN PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 45. INDIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 46. AUSTRALIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 47. SOUTH KOREA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 48. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 49. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 50. MIDDLE EAST & AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 51. UAE PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 52. SAUDI ARABIA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 53. SOUTH AFRICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 54. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE OVERVIEW, BY COUNTRY (2017) (US $ MN)
  • FIGURE 55. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 56. SOUTH AND CENTRAL AMERICA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%)
  • FIGURE 57. BRAZIL PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 58. ARGENTINA PERFUSION SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ MN)
  • FIGURE 59. GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2015-2018
  • FIGURE 60. ORGANIC GROWTH STRATEGIES IN THE PERFUSION SYSTEMS MARKET, 2016-2018
  • FIGURE 61. INORGANIC DEVELOPMENTS IN THE PERFUSION SYSTEMS MARKET, 2015-2018